DNX BIOPHARMACEUTICALS
DNX is a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of patients with life-long diseases. Founded in 2014 and headquartered in Irvine, CA, USA, DNX is pursuing the development of new therapeutic proteins utilizing a 21st century, half-life extension platform technology known as PASylation, which is in-licensed from XL-protein GmbH. XLp has granted DNX a worldwide exclusive license under its patents and know-how related to the PASylation technology to develop and commercialize several PASylated products.
DNX BIOPHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2014-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.dnxbio.com
Total Employee:
11+
Status:
Active
Contact:
+1 (949) 224 3849
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Apache Mobile Non Scaleable Content Google Apps For Business GoDaddy DNS GoDaddy Starfield Technologies
Similar Organizations
Nyken Theraputics
Nyken is a biopharmaceutical company
Xanthus Pharmaceuticals
Xanthus is a biopharmaceutical company.
Current Employees Featured
Founder
Investors List
EvoNexus
EvoNexus investment in Non Equity Assistance - DNX Biopharmaceuticals
